drugset / Trial / NCT05358535

Propofol and Etomidate Admixtures Comparisons Trial (PEAC Trial)

NCT05358535

Phase 3 Recruiting 200 enrolled University of Texas Southwestern Medical Center
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the hemodynamics and adverse event profile in comparison between two treatment arms, one using an admixture of propofol and etomidate at a ratio by volume of 25%/75% (P2E7), and one using an admixture of propofol and etomidate at a ratio by volume of 75%/25% (P7E2), for anesthesia during endoscopic procedures at the Clements University Hospital (CUH) endoscopy lab (Endo).

Timeline

Start
2022-09-19
Primary completion
2027-01
Completion
2027-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Etomidate Small molecule
Subject Propofol Small molecule

Indications

No indication recorded.